These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 22619110)
41. The t(1;9)(p34;q34) and t(8;12)(p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1. Hidalgo-Curtis C; Chase A; Drachenberg M; Roberts MW; Finkelstein JZ; Mould S; Oscier D; Cross NC; Grand FH Genes Chromosomes Cancer; 2008 May; 47(5):379-85. PubMed ID: 18205209 [TBL] [Abstract][Full Text] [Related]
42. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib. Landberg N; Dreimane A; Rissler M; Billström R; Ågerstam H Eur J Haematol; 2017 Nov; 99(5):442-448. PubMed ID: 28881484 [TBL] [Abstract][Full Text] [Related]
43. Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature. Kumar KR; Chen W; Koduru PR; Luu HS Am J Clin Pathol; 2015 May; 143(5):738-48. PubMed ID: 25873510 [TBL] [Abstract][Full Text] [Related]
44. A rare case report of 8p11 myeloid and lymphoid neoplasm with FGFR1 abnormality in a young adult. Shaaban H; Dabu J; Al-Rabi K; Gauchan D; Guron G Ann Hematol; 2013 Jan; 92(2):285-6. PubMed ID: 22941307 [No Abstract] [Full Text] [Related]
45. Myeloid/lymphoid neoplasm with CEP110-FGFR1 fusion: An analysis of 16 cases show common features and poor prognosis. Chen M; Wang K; Cai X; Zhang X; Chao H; Chen S; Shen H; Wang Q; Zhang R Hematology; 2021 Dec; 26(1):153-159. PubMed ID: 33491601 [No Abstract] [Full Text] [Related]
46. Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: a review of literature of t(8;13) associated myeloproliferative diseases. Wong WS; Cheng KC; Lau KM; Chan NP; Shing MM; Cheng SH; Chik KW; Li CK; Ng MH Leuk Res; 2007 Feb; 31(2):235-8. PubMed ID: 16777224 [TBL] [Abstract][Full Text] [Related]
47. A case of a patient characterized by t(8;22)(p11;q11) and BCR/FGFR1 fusion gene, who was successfully treated with haploidentical hematopoietic stem cell transplantation. Chen X; Huang L; Zheng C; Wang Z Hematology; 2021 Dec; 26(1):691-696. PubMed ID: 34493159 [No Abstract] [Full Text] [Related]
48. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1. Macdonald D; Reiter A; Cross NC Acta Haematol; 2002; 107(2):101-7. PubMed ID: 11919391 [TBL] [Abstract][Full Text] [Related]
49. Activity of fibroblast growth factor receptor inhibitors TKI258, ponatinib and AZD4547 against TPR‑FGFR1 fusion. Qiu XH; Li F; Cao HQ; Shao JJ; Mei JG; Li HQ; Zhai YP Mol Med Rep; 2017 Mar; 15(3):1024-1030. PubMed ID: 28138694 [TBL] [Abstract][Full Text] [Related]
50. The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP. Smedley D; Hamoudi R; Clark J; Warren W; Abdul-Rauf M; Somers G; Venter D; Fagan K; Cooper C; Shipley J Hum Mol Genet; 1998 Apr; 7(4):637-42. PubMed ID: 9499416 [TBL] [Abstract][Full Text] [Related]
51. The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene. Bousquet M; Quelen C; De Mas V; Duchayne E; Roquefeuil B; Delsol G; Laurent G; Dastugue N; Brousset P Oncogene; 2005 Nov; 24(48):7248-52. PubMed ID: 16091753 [TBL] [Abstract][Full Text] [Related]
52. [Clinical pathological features of the 8p11 myeloproliferative syndrome]. Yan Z; Yang B; Wang QS; Wang LL; Han XP; Ren F; Yu L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1321-6. PubMed ID: 21129285 [TBL] [Abstract][Full Text] [Related]
53. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13). Popovici C; Adélaïde J; Ollendorff V; Chaffanet M; Guasch G; Jacrot M; Leroux D; Birnbaum D; Pébusque MJ Proc Natl Acad Sci U S A; 1998 May; 95(10):5712-7. PubMed ID: 9576949 [TBL] [Abstract][Full Text] [Related]
54. Identification of a novel TFG-FGFR1 fusion gene in an acute myeloid leukaemia patient with t(3;8)(q12;p11). Wang T; Wang Z; Zhang L; Wen L; Cai W; Yang X; Pan J; Ruan C; Wu D; Sun A; Chen S Br J Haematol; 2020 Jan; 188(1):177-181. PubMed ID: 31802477 [No Abstract] [Full Text] [Related]
55. Diagnostic application of next-generation sequencing in ZMYM2-FGFR1 8p11 myeloproliferative syndrome: A case report. Wang Y; Wu X; Deng J; Yu H; Xu R; Zhu Z; Tu S; Hu Y Cancer Biol Ther; 2016 Aug; 17(8):785-9. PubMed ID: 27415155 [TBL] [Abstract][Full Text] [Related]
56. t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12. Chaffanet M; Popovici C; Leroux D; Jacrot M; Adélaïde J; Dastugue N; Grégoire MJ; Hagemeijer A; Lafage-Pochitaloff M; Birnbaum D; Pébusque MJ Oncogene; 1998 Feb; 16(7):945-9. PubMed ID: 9484786 [TBL] [Abstract][Full Text] [Related]
57. Characterization of 6q abnormalities in childhood acute myeloid leukemia and identification of a novel t(6;11)(q24.1;p15.5) resulting in a NUP98-C6orf80 fusion in a case of acute megakaryoblastic leukemia. Tosi S; Ballabio E; Teigler-Schlegel A; Boultwood J; Bruch J; Harbott J Genes Chromosomes Cancer; 2005 Nov; 44(3):225-32. PubMed ID: 16028218 [TBL] [Abstract][Full Text] [Related]
58. t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature. Wakim JJ; Tirado CA; Chen W; Collins R Leuk Res; 2011 Sep; 35(9):e151-3. PubMed ID: 21628071 [No Abstract] [Full Text] [Related]
59. Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13. Karakoula K; Suarez-Merino B; Ward S; Phipps KP; Harkness W; Hayward R; Thompson D; Jacques TS; Harding B; Beck J; Thomas DG; Warr TJ Genes Chromosomes Cancer; 2008 Nov; 47(11):1005-22. PubMed ID: 18663750 [TBL] [Abstract][Full Text] [Related]
60. Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3). Guasch G; Popovici C; Mugneret F; Chaffanet M; Pontarotti P; Birnbaum D; Pébusque MJ Blood; 2003 Jan; 101(1):286-8. PubMed ID: 12393597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]